Inventor · disambiguated record
Christian Fritz
Also filed as: FRITZ CHRISTIAN · FRITZ CHRISTIAN C
17 granted patents·5 pending applications·41 citations·filing 1996–2023
91Inventor score
Files withMILLENNIUM PHARM INC12SYROS PHARMACEUTICALS INC6INFINITY PHARMACEUTICALS INC2MILLENIUM PHARMACEUTICALS INC1UNIV MASSACHUSETTS1
Top patents by PatentIndex Score
22 records- 0190US9868994B2Methods of stratifying patients for treatment with retinoic acid receptor-α agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Jan 16, 2018·6 cites·22 claims
- 0285US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 0384US10240210B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Mar 26, 2019·2 cites·27 claims
- 0480US11053552B2Methods of stratifying patients for treatment with retinoic acid receptor-α agonistsSYROS PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·1 cites·22 claims
- 0572US6664074B2Use of yacM and yqeJ, essential bacterial genes and polypeptides and their useMILLENNIUM PHARM INC·Filed 2001·Granted Dec 16, 2003·2 cites·8 claims
- 0671US6749858B2Essential bacterial genes and their useMILLENNIUM PHARM INC·Filed 2002·Granted Jun 15, 2004·1 cites·9 claims
- 0769US2021285059A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0861US2024102106A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0957US6638729B2Use of YLQF, YQEG, YYBQ, and YSXC, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 2001·Granted Oct 28, 2003·1 cites·7 claims
- 1057US6627747B1Essential bacterial genes and their useMILLENIUM PHARMACEUTICALS INC·Filed 1999·Granted Sep 30, 2003·8 cites·5 claims
- 1156US6995134B2Use of yneS, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 2002·Granted Feb 7, 2006·0 cites·12 claims
- 1255US7329508B2Use of ylqF, yqeG, yybQ, and ysxC, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 2006·Granted Feb 12, 2008·0 cites·7 claims
- 1354US2003092024A1Essential bacterial genes and their useMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1453US7074585B2Use of ylqF, yqeG, yybQ, and ysxC, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 2004·Granted Jul 11, 2006·0 cites·3 claims
- 1551US6815177B2Use of ylqF, yqeG, yybQ, and ysxC, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 2003·Granted Nov 9, 2004·0 cites·4 claims
- 1647US6437108B1Essential bacterial genes and their useMILLENNIUM PHARM INC·Filed 1998·Granted Aug 20, 2002·4 cites·19 claims
- 1744US2016032387A1Methods and systems for evaluating genesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1840US5922856AHuman protein critical for HIV replicationUNIV MASSACHUSETTS·Filed 1996·Granted Jul 13, 1999·2 cites·14 claims
- 1938US2011118298A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancerINFINITY PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2036US6472377B1Use of YNES, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 1998·Granted Oct 29, 2002·1 cites·9 claims
- 2131US6372448B1Use of ylqF, yqeG, yybQ, and ysxC, essential bacterial genes and polypeptidesMILLENNIUM PHARM INC·Filed 1998·Granted Apr 16, 2002·0 cites·7 claims
- 2230US6515119B1Use of S-ydcB and B-ydcB, essential bacterial genesMILLENNIUM PHARM INC·Filed 1998·Granted Feb 4, 2003·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Christian Fritz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →